Can Type IV Collagen Serve as a Biomarker for Cancer?
Yes, type IV collagen and its degradation products can serve as potential biomarkers for cancer diagnosis and prognosis. Elevated levels of type IV collagen fragments in the blood or urine have been associated with various cancers, including breast, prostate, and colorectal cancers. These biomarkers can aid in early detection, monitoring disease progression, and evaluating treatment response.
